Fund Facts  

Inception Date: Aug 1, 1994
Ticker Symbol: AAIPX
Morningstar Category:Foreign Large Value
As of Mar 31, 2016
Fund Net Assets ($millions) $2,361

Documents for Fund or Underlying Fund(s)  

Description

Objective  

The investment seeks long-term capital appreciation.

Principal Investment Strategies  

The fund normally invests at least 80% of its net assets (plus the amount of any borrowings for investment purposes) in common stocks and securities convertible into common stocks (collectively, "stocks") of issuers based in at least three different countries located outside the United States. It primarily invests in countries comprising the Morgan Stanley Capital International Europe Australasia and Far East Index ("MSCI EAFE Index"). The MSCI EAFE Index is comprised of equity securities of companies from various industrial sectors whose primary trading markets are located outside the United States.

Principal Investment Risks  

There is no guarantee that the Fund will achieve its investment objective. You may lose money by investing in the Fund. Please see the Risk Glossary for additional information about the Fund’s risks.

 

Performance & Expenses

Standard Performance As of Mar 31, 2016
Fund/Benchmark Name QtrYTD1-Yr3-Yr5-Yr10-YrSince Inception
American Beacon Intl Equitya-3.24%-3.24%-9.94%2.11%2.02%1.83%6.24%
MSCI EAFE Index (Net)a,b-3.01%-3.01%-8.27%2.23%2.29%1.80%N/A
Morningstar Foreign Large Valuea,c-1.64%-1.64%-8.74%1.28%0.98%0.70%N/A

Fund past performance, as shown, is no guarantee of how the fund will perform in the future. The performance shown has been annualized for periods greater than one year. Investment returns and principal value will fluctuate, so that an investor's shares, when redeemed, may be worth more or less than their original cost. For current performance, visit www.icmarc.org.

Fund performance is shown comparing it to a "benchmark" which may be a (i) broad-based securities market index (ii) a group of mutual funds with similar investment objectives, or (iii) a short term government backed debt obligation such as a U.S. Treasury Bill. An index is not available for direct investment, is unmanaged, and does not reflect the costs of portfolio management or trading. A fund's portfolio may differ from the securities held in an index.

Annual Fund Operating Expenses
Total expensesa1.07%

 

a. Returns and/or expenses provided by Morningstar, Inc. Copyright © 2016. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. ICMA-RC does not independently verify Morningstar data.

b. The MSCI Europe Australasia Far East (EAFE) Index (Net) is a free float-adjusted market capitalization index of equity securities that is designed to measure the equity market performance of developed markets, excluding the U.S. and Canada. The net version of this index reinvests dividends after the deduction of withholding taxes, using a tax rate applicable to non-resident institutional investors who do not benefit from double taxation treaties.

c. The Morningstar Category Average is the equal-weighted average return of all funds per category, as identified by Morningstar, Inc.

Distributions

Dividends and Capital Gains  
Record Date Ex/Payable Date Income/Capital Gains Paid Per Share
Dec 22, 2015Dec 22, 2015$0.364600000
Dec 22, 2014Dec 22, 2014$0.458100000
Dec 20, 2013Dec 20, 2013$0.239300000
 

Morningstar Information

Morningstar Rating   As of Mar 31, 2016
Period Stars Category Size
Overall 4 Stars289
3-Year 3 Stars289
5-Year 4 Stars251
10-Year 4 Stars133

For each fund with at least a three-year history, Morningstar calculates a Morningstar Rating™ based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a fund's monthly performance (including the effects of sales charges, loads, fee waivers, and redemption fees), placing more emphasis on downward variations and rewarding consistent performance. The top 10% of funds in each category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars and the bottom 10% receive 1 star. The Overall Morningstar Rating for a fund is derived from a weighted average of the performance figures associated with its three-, five- and ten-year (if applicable) Morningstar Rating metrics. For funds with loads, the Morningstar rating on a load-waived basis is provided, when available. Load-waived ratings do not include any front- or back-end sales loads and are intended for investors that have access to such purchase terms. Funds with loads are waived for plans administered by ICMA-RC. Past performance is no guarantee of future results.

Morningstar Stylebox As of Mar 31, 2016
Equity Stylebox
Large Value
Allocation of Assets As of Jan 31, 2016
Type of Asset Percent
Equity92%
Fixed Income0%
Cash/Other8%

Due to rounding, percentages shown may not add up to 100%.

 
 

Characteristics

Allocation of Assets As of Jan 31, 2016
Asset ClassPercent
Domestic Stock2.1%
Foreign Stock89.7%
Domestic Bond0.0%
Foreign Bond0.0%
Preferred0.0%
Convertible0.0%
Cash5.1%
Other3.1%

Due to rounding, percentages shown may not add up to 100%.

 
Equity Sector As of Jan 31, 2016
SectorPercent
Financial Services19.5%
Healthcare11.6%
Consumer Cyclical10.9%
Consumer Defensive8.7%
Communication Services8.1%
Energy7.7%
Industrials7.4%
Basic Materials5.8%
Technology5.6%
Utilities2.0%
Real Estate1.5%

Exposure reflects equity securities only and will sum to the equity exposure of the fund.

 
Top Ten Country Exposure As of Jan 31, 2016
CountryPercent
United Kingdom21.0%
Japan14.0%
France10.2%
Germany7.8%
Switzerland7.6%
Netherlands4.3%
South Korea4.1%
United States2.0%
Canada2.0%
Sweden2.0%
Top Ten Holdings As of Jan 31, 2016
Holding NamePercent
Novartis AG2.4%
British American Tobacco PLC2.1%
KDDI Corp1.9%
Lloyds Banking Group PLC1.7%
Bayer AG1.7%
Total SA1.7%
Teva Pharmaceutical Industries Ltd ADR1.6%
Akzo Nobel NV1.4%
Roche Holding AG Dividend Right Cert.1.3%
Topix Indx Futr Mar16 Xose 201603101.2%
 

Statistics

Portfolio Statistics As of Mar 31, 2016
Statistic3-Year5-Year
Beta0.880.94
Alpha3.232.99
Standard Deviation13.4715.93
 
 

Footnotes

1.

Please read the fund's prospectus carefully for a complete summary of all fees, expenses, investment objectives and strategies, risks, financial highlights, and performance information. Investing involves risk, including possible loss of the amount invested. Investors should carefully consider the information contained in the prospectus before investing. You may contact us to obtain a prospectus or to answer questions by calling 800-669-7400, emailing investorservices@icmarc.org, or visiting www.icmarc.org.

The source for this information is Morningstar, Inc. Copyright © 2016 Morningstar, Inc.® All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Morningstar, Inc. is a global investment research firm that is not affiliated with ICMA-RC. ICMA-RC does not independently verify Morningstar data.

Morningstar places funds in certain categories based on the fund's historical portfolio holdings. Placement of a fund in a particular Morningstar category does not mean that the fund will remain in that category or that it will invest primarily in securities consistent with its Morningstar category. A fund's investment strategy and portfolio holdings are governed by its prospectus, guidelines or other governing documents, not its Morningstar category.